ViBA

Digital twin simulations with a micro-multiphysics agent-based model reveal key drivers of bone loss after denosumab discontinuation.

Ledoux C, Kendall JJ, Boaretti D · Frontiers in bioengineering and biotechnology · 2025 · Article

10.3389/fbioe.2025.1652201

Verified evidence

Model scenario comparison

413bd7a9-56ef-5eb4-a202-d60356d35062
Bone mineral contentStatistical test outcomes

Prediction source Version of record · PDF page(s) 1, 4

Study af301a6f-54a0-5c74-9d90-550608e0971f · Prediction record (JSON)

Prediction fields

Endpoint
post_denosumab_bone_mineral_loss__mixed_effects_regression · PDF page(s) 1, 4
Family
bone_mineral_content · PDF page(s) 1, 4
Measured variable
post_denosumab_bone_mineral_loss · PDF page(s) 1, 4
Measurement role
reference_agreement · PDF page(s) 1, 4
Metric
mixed_effects_regression · PDF page(s) 1, 4
Population
simulated_system · PDF page(s) 1, 4, 12
Reference type
alternative_computational_methods · PDF page(s) 1, 4
Role
model_fit · PDF page(s) 1, 4
Scenario
alternative_computational_methods · PDF page(s) 1, 4